Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer
ConclusionThe use of a direct oral anticoagulant as extended venous thromboembolism prophylaxis after major gastrointestinal surgery has not been studied to date. These results show dabigatran to be a safe alternative to low-molecular-weight heparin for extended venous thromboembolism prophylaxis with regard to bleeding complications.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Bleeding | Brain | Cancer | Cancer & Oncology | Gastroenterology | Insurance | Lovenox | Neurology | Neurosurgery | Oral Cancer | Orthopaedics | Pancreas | Pancreatic Cancer | Pradaxa | Study | Surgery | Thrombosis